Vedanta Biosciences to Present at Upcoming Investor Conferences

On July 7, 2022 Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, reported that members of its executive team will participate at the following investor conferences (Press release, Vedanta Biosciences, JUL 7, 2022, View Source [SID1234616542]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William Blair Biotech Focus Conference
Dates: July 12-13, 2022
Location: St. Regis Hotel, New York, NY
A pre-recorded fireside chat will be made available on the William Blair conference website starting on Monday, July 11, 2022.

SVB Securities Biopharma Private Company Connect
Dates: July 20-21, 2022
Virtual 1×1 meetings only